Epinephrine is a prescription drug that can be used to treat life-threatening allergic emergencies. The adrenaline is offered by TEVA, a worldwide leader in generic drugs and specialty medicines, in single-dose, prefilled disposable autoinjectors.

For this injector, Schreiner MediPharm developed a label with abrasion- and scratch-resistant reverse printing. It is particularly resistant against chemical and mechanical impacts which the autoinjector is exposed to while being carried, for instance, in a purse or backpack. The special material construction and design that is precisely adapted to the sophisticated shape of the autoinjector ensure that the marking label reliably adheres to the device. Consequently, the vital information about the product and its use is perfectly legible and always readily available. There is no need for an additional cover protecting the label against abrasion or separation. This means less waste and a smaller environmental footprint. For product and patient safety, the label has a perforation: it clearly and irreversibly indicates any first opening of the cap and potential tampering attempt.

In 2019, the North American Tag and Label Manufacturers Institute (TLMI) recognized the TEVA Autoinjector-Label in its annual awards competition. Schreiner MediPharm’s product development won second place in the “Multi-Process” category.